Mandate

Vinge advises sellers in connection with divestment in Solör

December 17, 2021 M&A

Vinge advises Vantage Consulting Group in connection with Highview Finance Holding Company DAC’s divestment of its shares in Solör Bioenergi Holding AB (“Solör”) to the other existing shareholders Polhem Infra and Nordic Infrastructure.

Solör is a privately owned energy company within sustainable energy based on wood fuels and district heating in Sweden and Norway. Polhem Infra is an investment company wholly owned by the Swedish State Pension Funds AP1, AP3 and AP4, and NIAG is the majority owner of Solör. In connection with the divestment, Polhem Infra and Nordic Infrastructure acquired a total of 21.05 percent of the shares in Solör.

Vinge’s team consisted of Johan Göthberg, Maria Dahlin Kolvik, Eléonore Friberg and Ebba Nyberg.

 

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026